1. Ua ʻōlelo ʻo HKU e hiki ke hoʻohui ʻia ka maʻi maʻi COVID-19 ihu a me ka maʻi maʻi influenza i hoʻokahi.
Ua ʻae ʻia ka lāʻau lapaʻau nasal COVID-19 e ke Kulanui o Hong Kong, Xiamen University a me Beijing Wantai Biological Pharmaceutical Co., Ltd. i ʻae ʻia e ka State Drug Administration no ka hoʻohana pilikia ma ka ʻāina nui.Ua pane ke Kulanui o Hong Kong i ka nīnau a ka mea hoʻolaha ʻo China News Service ʻo kekahi o nā hiʻohiʻona o kēia kano COVID-19 nasal hiki ke hoʻohui ʻia me ka maʻi influenza.
2. Ua hana ʻo Waterloo, kahi ʻano like ʻole 3 biliona, i "lei kūʻai" hou o nā antiemetics!
ʻO ka nausea a me ka luaʻi i hana ʻia e ka chemotherapy kekahi o nā hopena ʻino loa o nā maʻi maʻi maʻi.Hoʻokaʻawale ʻia nā lāʻau anti-emetics a me nā lāʻau anti-nausea e like me ka digestive system a me nā lāʻau metabolic, akā hoʻohana nui ʻia lākou i ka mālama ʻana i ka luaʻi i hoʻokumu ʻia e nā lāʻau anti-tumor i ka hoʻomaʻamaʻa lapaʻau, a he hana koʻikoʻi i ke kahua o ka mālama ʻana i ka maʻi maʻi.Wahi a ka ʻikepili mai Minei.com, ʻo ka nui o ka mākeke o nā antiemetics a me nā lāʻau antinausea ma nā kikowaena o nā keʻena olakino lehulehu ma Kina i ka hapa mua o 2022 ua ʻoi aku ma mua o 2.9 biliona yuan.Ua hoʻomau ʻo Qilu Pharmaceutical i ke alakaʻi ʻana i ka mākeke.Ua holo wikiwiki ʻo Zhengda Tianqing Pharmaceutical Group i TOP2.Ua komo nā lāʻau lapaʻau hou ʻo Hengrui Class 1 i ka Phase III i ka hoʻomaʻamaʻa lapaʻau, a ua kokoke e hoʻomaka kahi pōʻai hou o ka shuffling brand.
3. Ua wela ka track anti R&D pālua!Ua ʻike ʻo Xinda a me nā hui ʻē aʻe i kahi mākeke ʻoi aku ka nui ma mua o 200 biliona
I kēia mau lā, ua wela ka mākeke kūʻai lāʻau ʻelua: ʻO Kangfang Biotech a me Summit Therapeutics ua hōʻea i kahi kālepa laikini o nā ʻāina ʻē a hiki i 5 biliona kālā ʻAmelika no ka huahana anti drug AK112, a me Wuhan Youzhiyou Biotech, kahi noiʻi a me ka hoʻomohala ʻana i ka lāʻau lapaʻau ʻelua. ʻoihana, ua hoʻouna i kāna palapala noi IPO… Ke alakaʻi ʻia nei e ka mākeke maikaʻi, hoʻokipa pū ka ʻelua anti drug i ka boom noiʻi a me ka hoʻomohala ʻana.I kēia manawa, aia ma kahi o 80 mau ʻano o nā antibodies pālua i ka pae lapaʻau ma Kina.ʻO Xinda Bio, Shiyao Holding, Roche, a me nā mea ʻē aʻe he ʻehā a ʻoi aku paha nā huahana ma lalo o ka noiʻi.He ʻumikūmākolu huahana o Hengrui Pharmaceutical, e like me SHR-1701, Baiji Shenzhou's Zanidatamab, aia i loko o ka lāʻau lapaʻau III.ʻO nā antibodies pālua e pili ana i nā pahuhopu CD47 / PD-L1 ka mea kaulana loa, a ʻelima mau huahana e hele nei i nā hoʻokolohua lapaʻau.Ua hoʻokumu ʻo CDE i nā kumu alakaʻi no nā pilikia e pono ai ka nānā wikiwiki ʻana i ka noiʻi lapaʻau a me ka hoʻomohala ʻana i nā lāʻau anti-tumor pālua, E alakaʻi i nā ʻoihana e hana hou i ka noiʻi lapaʻau ʻepekema a me ka hoʻomohala ʻana i nā antibody pālua.
4. Ua paʻi ka maʻi maʻi maʻi ʻino loa i nā makahiki he ʻumi i hala!Ua piʻi ka nui o nā hale hoʻokipa ma nā mokuʻāina ʻo US
Wahi a ka hōʻike ma ka 5 o ka manawa kūloko o Axios, ka pūnaewele nūhou US, ʻo ka maʻi maʻi ʻino loa ma mua o hoʻokahi mau makahiki ua paʻi i ka ʻōnaehana olakino a me ke olakino e pili ana i ka hiolo ma muli o ka maʻi maʻi COVID-19 a me ka respiratory syncytial. virus (RSV).
Ua hōʻike ʻia ua hana ka maʻi maʻi i kēlā me kēia mokuʻāina i kahi kiʻekiʻe a kiʻekiʻe loa o ka hana maʻi influenza.
Wahi a ka US Centers for Disease Control and Prevention (CDC), ua aneane pālua ka nui o nā halemai pili i ka maʻi maʻi i ka wā Hoʻomaikaʻi mai ka pule i hala aku nei, ʻo ka mea kiʻekiʻe loa mai ka makahiki 2010-2011.Ma waena o lākou, ʻoi aku ka nui o nā poʻe makua 65 a ʻoi aʻe a me nā keiki ma lalo o 4 mau makahiki, ʻoiai inā loaʻa iā lākou nā pilikia olakino.
Eia nō naʻe, ma kahi o 40% o nā ʻAmelika i ʻōlelo ʻaʻole lākou i hoʻolālā e hoʻopaʻa i ka maʻi influenza i kēia kau, no ka mea, hopohopo lākou i ka hopena maikaʻi ʻole a i ʻole nā hopena ʻaoʻao o ke kano.
Ua ʻōlelo ka poʻe loea olakino i nā makahiki ʻelua i hala iho nei, ua hoʻopaʻa nui nā masks a me nā mea ʻē aʻe o ka maʻi maʻi COVID-19 i ka maʻi maʻi maʻi a kāohi i kāna hoʻouna ʻana i ka wā.Eia naʻe, i ka hoʻi ʻana o nā kānaka i ko lākou ola ma mua o ka maʻi maʻi, ʻoi aku ka maʻalahi o lākou i ka maʻi.
I ka makahiki i hala aku nei, ua wānana kahi hui noiʻi i ka wā i wehe ʻia ai nā hana pale pilikino, e piʻi hou ka maʻi maʻi o nā keiki.Ua koi ka poʻe noiʻi i ka hoʻokō ʻana i kahi "hoʻolālā lapaʻau hahai".
Manaʻo ʻo CDC, a hiki i kēia manawa, ma kahi o 8.7 miliona mau kānaka i maʻi, 78000 i mālama ʻia i ka haukapila a 4500 i make i ka wā maʻi.
Wahi a CNN, ua hoʻohiki ke aupuni Biden e hāʻawi i nā kumuwaiwai a me nā limahana e kōkua i ka ʻōnaehana olakino kūloko e hoʻokō i ka piʻi ʻana o ka maʻi maʻi, akā ʻaʻole ia e noʻonoʻo e haʻi i kahi pilikia olakino olakino.
Wahi a ka ʻikepili CDC, ma waena o 2009 a me 2022, ʻoi aku ka nui o ka maʻi maʻi influenza o nā poʻe ʻAmelika ʻAmelika ma kahi o 80% kiʻekiʻe ma mua o nā pākeke keʻokeʻo.Eia nō naʻe, i ka wā o ka maʻi maʻi 2021-2022, ʻoi aku ka liʻiliʻi ma mua o 43% o ʻAmelika ʻAmelika, Hispanic a me ʻAmelika ʻAmelika i hoʻopaʻa ʻia.
Ma kahi leka i nā mokuʻāina, ua kākau ke Kakauolelo o ka US Department of Health and Human Services, Xavier Bessela, hiki i ke aupuni federal ke komo i ke kōkua ʻana i ka ʻōnaehana olakino e kū nei i ke kaomi, e like me ka ʻae ʻana i nā haukapila me ka hapa o nā limahana e hauʻoli i ka hoʻokuʻu ʻia e hoʻonui. ka hiki ke mālama i nā maʻi, a i ʻole e hoʻolilo iā lākou i mea e hoʻoneʻe i nā maʻi me ka maʻi maʻi, COVID-19 a i ʻole RSV.
ʻO JinDun Medicalloaʻa i ka hui noiʻi ʻepekema lōʻihi a me ka grafting ʻenehana me nā kulanui Kina.Me nā waiwai lapaʻau waiwai o Jiangsu, loaʻa iā ia nā pilina kālepa lōʻihi me India, Asia Hema, South Korea, Iapana a me nā mākeke ʻē aʻe.Hāʻawi pū ia i nā lawelawe mākeke a me ke kūʻai aku i ke kaʻina holoʻokoʻa mai waena a hiki i ka huahana huahana API.E hoʻohana i nā kumuwaiwai i hōʻiliʻili ʻia o Yangshi Chemical i loko o ka kemika fluorine e hoʻolako i nā lawelawe hana hana kemika kūikawā no nā hoa.Hāʻawi i nā lawelawe noiʻi kaʻina hana a me ka haumia i nā mea kūʻai aku.
Ke koi nei ʻo JinDun Medical i ka hoʻokumu ʻana i kahi hui me nā moeʻuhane, hana i nā huahana me ka hanohano, meticulous, rigorous, a hele i nā mea a pau e lilo i hoa hilinaʻi a me ka hoaaloha o nā mea kūʻai aku! ʻoihanahana lāʻau lapaʻau maʻamau(CMO) a me nā mea lawelawe R&D lāʻau lapaʻau maʻamau a me ka hana (CDMO).E hele pū ʻo Jindun iā ʻoe e hoʻolilo iā COVID-19.
Ka manawa hoʻouna: Dec-16-2022